Currently, Jean-Paul Kress holds the position of CEO & Chairman-Management Board at MorphoSys AG and President & Director at Syntimmune, Inc.

In his past career he was President-International & Executive Vice President at Biogen, Inc., Senior Vice President & Head-North America at Genzyme Corp., Chairman for ERYTech Pharma SA and President & Chief Executive Officer for Sanofi Pasteur MSD SNC.

Dr. Kress received an undergraduate degree and a graduate degree from École Normale Supérieure and a doctorate from Faculté De Médecine Necker Enfants Malades Université.